The history of copyright's flagship drug presents a interesting case for stakeholders in the drug sector. While initially a phenomenal success, generating vast sums, the patent expiration and the subsequent entry of generic versions have significantly impacted revenue. This raises questions about the ongoing profitability of analogous therapeuti… Read More